IN8BIO, INC. Employee Benefits and Share-based Compensation
IN8BIO, INC. (INAB) reported Employee Benefits and Share-based Compensation of $800.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-07.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2026-03-12
- IN8BIO, INC. employee benefits and share-based compensation for the quarter ending 2025-03-31 was $800.00K.
- IN8BIO, INC. employee benefits and share-based compensation for fiscal 2024 was $800.00K.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|
| 2025-03-31 | $800.00K 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $800.00K 10-K · filed 2026-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |